Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
3 insiders in a week, 7th time since 2022Traded Jun 1 · filed 1 day later
Since the trade −23.1% · S&P 500 −0.6% · to Nov 13
The CEO of Maia Biotechnology paid $101K out of pocket for Maia Biotechnology shares. 2 other people at Maia Biotechnology bought some too, in the same month. It was the first purchase in 7 months.
5 insiders in a week, 3rd time since 2020Traded May 29 · filed 4 days later
Since the trade −27.3% · S&P 500 −0.3% · to Nov 13
The CEO of Processa Pharmaceuticals paid $5.5K out of pocket for Processa Pharmaceuticals shares. 5 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 27% with this purchase.
Since the trade −25.0% · S&P 500 −0.3% · to Nov 13
Cava's Chief Operations Officer paid $195K out of pocket for Cava shares. 1 other person at Cava bought some too, in the same month. Shares held went up 24% with this purchase.
5 insiders in a week, 3rd time since 2020Traded May 29 · filed 4 days later
Since the trade −27.3% · S&P 500 −0.3% · to Nov 13
The CFO of Processa Pharmaceuticals paid $5.9K out of pocket for Processa Pharmaceuticals shares. 5 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 27% with this purchase.
Their first buy on recordTraded May 29 · filed 4 days later
Since the trade −25.0% · S&P 500 −0.3% · to Nov 13
Cava's CLO & Secretary paid $79K out of pocket for Cava shares. 1 other person at Cava bought some too, in the same month. Shares held went up 20% with this purchase.
3 insiders in a week, 7th time since 2022Traded Jun 1 · filed 1 day later
Since the trade −23.1% · S&P 500 −0.6% · to Nov 13
A Maia Biotechnology director paid $100K out of pocket for Maia Biotechnology shares. 2 other people at Maia Biotechnology bought some too, in the same month. It was the first purchase in 6 months.
5 insiders in a week, 3rd time since 2020Traded May 29 · filed 4 days later
Since the trade −27.3% · S&P 500 −0.3% · to Nov 13
Processa Pharmaceuticals's Chief Business - Strategy Off paid $4.1K out of pocket for Processa Pharmaceuticals shares. 5 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 21% with this purchase.
5 insiders in a week, 3rd time since 2020Traded May 29 · filed 4 days later
Since the trade −27.3% · S&P 500 −0.3% · to Nov 13
Processa Pharmaceuticals's Chief Administrative Officer paid $4.7K out of pocket for Processa Pharmaceuticals shares. 5 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 23% with this purchase.
5 insiders in a week, 3rd time since 2020Traded May 29 · filed 4 days later
Since the trade −27.3% · S&P 500 −0.3% · to Nov 13
A Processa Pharmaceuticals director paid $4.6K out of pocket for Processa Pharmaceuticals shares. 5 other people at Processa Pharmaceuticals bought some too, in the same month. Shares held went up 12% with this purchase.